newsfilter
← Latest News
GlobeNewswire·

Iterum Therapeutics to Report First Quarter 2024 Financial Results on May 13, 2024

DUBLIN, Ireland and CHICAGO, May 06, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (NASDAQ:ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics